The effect of CDK4 inhibitor to AML

被引：0
|
作者：
wang, Jie [1 ]
机构：
[1] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] The effect of hypoxia on cyclin dependent kinase 4 (cdk4)
    Zygmunt, A
    Blatney, Z
    Krucher, NA
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 451A - 451A
  • [42] Factors that limit delivery of Cdk4/6 inhibitor palbociclib to GBM
    Parrish, K.
    Pokorny, J.
    Mittapalli, R.
    Bakken, K.
    Sarkaria, J.
    Elmquist, W.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 86 - 86
  • [43] Therapeutic targeting of CDK4/6 inhibitor resistant breast cancer
    Lim, Elgene
    Portman, Neil
    Alexandrou, Sarah
    Haupt, Susan
    Haupt, Ygal
    Caldon, Elizabeth
    CANCER RESEARCH, 2018, 78 (04)
  • [44] CDK4/6 inhibitor-related neurological and psychiatric disorders
    Reactions Weekly, 2024, 2031 (1) : 6 - 6
  • [45] CDK4/6 inhibitor resistance: Biological mechanisms and novel approaches
    Hanker, Ariella
    CANCER RESEARCH, 2023, 83 (05)
  • [46] Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Dickson, Mark Andrew
    Keohan, Mary Louise
    Tap, William D.
    Antonescu, Cristina
    Landa, Jonathan
    Qin, Li-Xuan
    Dohrenwend, Eric Gerard
    Rathbone, Dustin
    Ustoyev, Yelena
    Condy, Mercedes M.
    Singer, Samuel
    Schwartz, Gary K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
    Javier Martin-Broto
    Jeronimo Martinez-Garcia
    David S. Moura
    Andres Redondo
    Antonio Gutierrez
    Antonio Lopez-Pousa
    Javier Martinez-Trufero
    Isabel Sevilla
    Roberto Diaz-Beveridge
    Maria Pilar Solis-Hernandez
    Amancio Carnero
    Marco Perez
    David Marcilla
    Jesus Garcia-Foncillas
    Pablo Romero
    Javier Fernandez-Jara
    Daniel Lopez-Lopez
    Ivan Arribas
    Nadia Hindi
    Signal Transduction and Targeted Therapy, 8
  • [48] Discovery of PF-07220060, a potent and selective CDK4 inhibitor
    Anders, Lars
    Gallego, Gary
    CANCER RESEARCH, 2024, 84 (07)
  • [49] MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
    Andrikopoulou, Angeliki
    Shalit, Almog
    Zografos, Eleni
    Koutsoukos, Konstantinos
    Korakiti, Anna-Maria
    Liontos, Michalis
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    CANCERS, 2021, 13 (16)
  • [50] CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)
    Huang, Jinyao
    Zheng, Liang
    Sun, Zicheng
    Li, Jie
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2022, 50 (04)
12345